• Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products under Tilray and Aphria brands
  • Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey
  • Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products
  • Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
  • Tilray Stock (TSX:TLRY) opened the day’s trading at $4.88 per share

Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands.

Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey.

“We’re proud to expand our medical cannabis portfolio in Canada and broaden our offerings for our growing patient community,” said Blair MacNeil, President, Tilray Canada.

“Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed,” he added.

In Canada, Tilray Medical offers a broad portfolio of medical cannabis brands including Tilray, Aphria, Broken Coast, and Symbios.

Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products.

Under the Tilray and Aphria brands, the company released Tilray Sinaloa Gold, Tilray Sapphire Scout, Tilray Chem Cookies, and Tilray Powdered Donuts #8. And under the Aphria brands, it released Aphria Sherbet Cookies, Aphria Banana Punch, and Aphria Monkey Butter.

To further support the medical cannabis journey for patients, Tilray Medical partnered with Strainprint, a mobile app focused on medical cannabis tracking, to develop the CannaPoints
program.

Alongside advice from a physician, Tilray Medical patients can use the CannaPoints program to explore new offerings, learn more about strain details, and record the effects, making it easier for them to curate optimal personal consumption schedules, empowering them to tailor their own experiences and earn rewards through the app in the process.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis.


More From The Market Online

Tilray’s Breckenridge Brewery honors Denver Nuggets with new ale

Breckenridge Brewery, a subsidiary of Tilray Brands, launches a new ale to honor the 2023 NBA championship-winning Denver Nuggets.

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Organigram looks to raise capital as cannabis stocks surge

Organigram (TSX:OGI), one of Canada's first cannabis stocks, announces an overnight marketed public offering of units for up to C$25 million.